Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Biocept's Total Stockholders Equity for the quarter that ended in Jun. 2023 was $0.29 Mil. Biocept's Total Assets for the quarter that ended in Jun. 2023 was $22.10 Mil.
Therefore, Biocept's Equity to Asset Ratio for the quarter that ended in Jun. 2023 was 0.01.
The historical rank and industry rank for Biocept's Equity-to-Asset or its related term are showing as below:
BIOCQ'
s Equity-to-Asset Range Over the Past 10 Years
Min: -9.37 Med: 0.52 Max: 0.83
Current: 0.01
During the past 12 years, the highest Equity to Asset Ratio of Biocept was 0.83. The lowest was -9.37. And the median was 0.52.
BIOCQ's Equity-to-Asset is ranked worse than 88.28% of 239
companies
in the Medical Diagnostics & Research industry
Industry Median: 0.58
vs BIOCQ: 0.01
Biocept Equity-to-Asset Historical Data
The historical data trend for Biocept's Equity-to-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Diagnostics & Research subindustry, Biocept's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Biocept Equity-to-Asset Distribution
For the Medical Diagnostics & Research industry and Healthcare sector, Biocept's Equity-to-Asset distribution charts can be found below:
* The bar in red indicates where Biocept's Equity-to-Asset falls into.
Biocept Equity-to-Asset Calculation
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
Biocept's Equity to Asset Ratio for the fiscal year that ended in Dec. 2022 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Biocept (OTCPK:BIOCQ) Equity-to-Asset Explanation
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
Biocept Equity-to-Asset Related Terms
Thank you for viewing the detailed overview of Biocept's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.
Biocept Inc develops and commercializes molecular diagnostic assays that provide physicians with clinically actionable information for treating and monitoring patients diagnosed with a variety of cancers. In addition to its portfolio of blood-based liquid biopsy assays, Biocept has developed the CNSide cerebrospinal fluid assay that detects cancer that has metastasized to the central nervous system. Biocept's patented Target Selector technology captures and quantitatively analyzes CSF tumor cells for tumor-associated molecular markers, using technology first developed for use in blood. It is also leveraging its molecular diagnostic capabilities to offer nationwide COVID-19 RT-PCR testing to support public health efforts during this unprecedented pandemic.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
BIOCQ has been successfully added to your 